{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:25:12Z","timestamp":1793157912715,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T00:00:00Z","timestamp":1642377600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T00:00:00Z","timestamp":1642377600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81672495, 81771489, 82072804, 82071559, and 82071558"],"award-info":[{"award-number":["81672495, 81771489, 82072804, 82071559, and 82071558"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Recently, a hotspot mutation in prolactinoma was observed in splicing factor 3b subunit 1 (\n                      <jats:italic>SF3B1<\/jats:italic>\n                      <jats:sup>\n                        <jats:italic>R625H<\/jats:italic>\n                      <\/jats:sup>\n                      ), but its functional effects and underlying molecular mechanisms remain largely unexplored.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Using the CRISPR\/Cas9 genome editing system and rat pituitary GH3 cells, we generated heterozygous\n                      <jats:italic>Sf3b1<\/jats:italic>\n                      <jats:sup>\n                        <jats:italic>R625H<\/jats:italic>\n                      <\/jats:sup>\n                      mutant cells. Sanger and whole-genome sequencing were conducted to verify the introduction of this mutation. Transcriptome analysis was performed in\n                      <jats:italic>SF3B1<\/jats:italic>\n                      -wild-type versus mutant human prolactinoma samples and GH3 cells. RT-PCR and minigene reporter assays were conducted to verify aberrant splicing. The functional consequences of\n                      <jats:italic>SF3B1<\/jats:italic>\n                      <jats:sup>\n                        <jats:italic>R625H<\/jats:italic>\n                      <\/jats:sup>\n                      were evaluated in vitro and in vivo. Critical makers of epithelial-mesenchymal transition and key components were detected using western blot, immunohistochemistry, and immunofluorescence. Suppressing proteins was achieved using siRNA.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Transcriptomic analysis of prolactinomas and heterozygous mutant cells revealed that the\n                      <jats:italic>SF3B1<\/jats:italic>\n                      <jats:sup>\n                        <jats:italic>R625H<\/jats:italic>\n                      <\/jats:sup>\n                      allele led to different alterations in splicing properties, affecting different genes in different species. SF3B1\n                      <jats:sup>R625H<\/jats:sup>\n                      promoted aberrant splicing and DLG1 suppression in both rat cells and human tumors. In addition, SF3B1\n                      <jats:sup>R625H<\/jats:sup>\n                      and knocking down DLG1 promoted cell migration, invasion, and epithelial-mesenchymal transition through PI3K\/Akt pathway.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Our findings elucidate a mechanism through which mutant SF3B1 promotes tumor progression and may provide a potent molecular therapeutic target for prolactinomas with the\n                      <jats:italic>SF3B1<\/jats:italic>\n                      <jats:sup>\n                        <jats:italic>R625H<\/jats:italic>\n                      <\/jats:sup>\n                      mutation.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13046-022-02245-0","type":"journal-article","created":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T03:24:24Z","timestamp":1642389864000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["The SF3B1R625H mutation promotes prolactinoma tumor progression through aberrant splicing of DLG1"],"prefix":"10.1186","volume":"41","author":[{"given":"Jing","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuzhong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyue","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulou","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazhuo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,17]]},"reference":[{"issue":"suppl_4","key":"2245_CR1","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/noy131","volume":"20","author":"QT Ostrom","year":"2018","unstructured":"Ostrom QT, Gittleman H, Truitt G, Boscia A, Kruchko C, Barnholtz-Sloan JS. CBTRUS statistical report: primary Brain and other central nervous system tumors diagnosed in the United States in 2011\u20132015. Neuro Oncol. 2018;20(suppl_4):iv1\u2013iv86.","journal-title":"Neuro Oncol"},{"issue":"3","key":"2245_CR2","doi-asserted-by":"publisher","first-page":"527","DOI":"10.3171\/2014.5.JNS131819","volume":"121","author":"H Gittleman","year":"2014","unstructured":"Gittleman H, Ostrom QT, Farah PD, Ondracek A, Chen Y, Wolinsky Y, et al. Descriptive epidemiology of pituitary tumors in the United States, 2004-2009. J Neurosurg. 2014;121(3):527\u201335.","journal-title":"J Neurosurg"},{"issue":"1","key":"2245_CR3","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1159\/000497746","volume":"109","author":"L Vroonen","year":"2019","unstructured":"Vroonen L, Daly AF, Beckers A. Epidemiology and management challenges in Prolactinomas. Neuroendocrinology. 2019;109(1):20\u20137.","journal-title":"Neuroendocrinology"},{"issue":"7280","key":"2245_CR4","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nature08909","volume":"463","author":"TW Nilsen","year":"2010","unstructured":"Nilsen TW, Graveley BR. Expansion of the eukaryotic proteome by alternative splicing. Nature. 2010;463(7280):457\u201363.","journal-title":"Nature"},{"key":"2245_CR5","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1146\/annurev-biochem-060614-034316","volume":"84","author":"Y Lee","year":"2015","unstructured":"Lee Y, Rio DC. Mechanisms and regulation of alternative pre-mRNA splicing. Annu Rev Biochem. 2015;84:291\u2013323.","journal-title":"Annu Rev Biochem"},{"issue":"19","key":"2245_CR6","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1038\/onc.2015.318","volume":"35","author":"A Sveen","year":"2016","unstructured":"Sveen A, Kilpinen S, Ruusulehto A, Lothe RA, Skotheim RI. Aberrant RNA splicing in cancer; expression changes and driver mutations of splicing factor genes. Oncogene. 2016;35(19):2413\u201327.","journal-title":"Oncogene"},{"key":"2245_CR7","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1146\/annurev.bi.65.070196.002055","volume":"65","author":"A Kramer","year":"1996","unstructured":"Kramer A. The structure and function of proteins involved in mammalian pre-mRNA splicing. Annu Rev Biochem. 1996;65:367\u2013409.","journal-title":"Annu Rev Biochem"},{"issue":"15","key":"2245_CR8","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1056\/NEJMoa1103283","volume":"365","author":"E Papaemmanuil","year":"2011","unstructured":"Papaemmanuil E, Cazzola M, Boultwood J, Malcovati L, Vyas P, Bowen D, et al. Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts. N Engl J Med. 2011;365(15):1384\u201395.","journal-title":"N Engl J Med"},{"issue":"26","key":"2245_CR9","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1056\/NEJMoa1109016","volume":"365","author":"L Wang","year":"2011","unstructured":"Wang L, Lawrence MS, Wan Y, Stojanov P, Sougnez C, Stevenson K, et al. SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. N Engl J Med. 2011;365(26):2497\u2013506.","journal-title":"N Engl J Med"},{"issue":"7403","key":"2245_CR10","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/nature11154","volume":"486","author":"S Banerji","year":"2012","unstructured":"Banerji S, Cibulskis K, Rangel-Escareno C, Brown KK, Carter SL, Frederick AM, et al. Sequence analysis of mutations and translocations across breast cancer subtypes. Nature. 2012;486(7403):405\u20139.","journal-title":"Nature"},{"issue":"7424","key":"2245_CR11","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nature11547","volume":"491","author":"AV Biankin","year":"2012","unstructured":"Biankin AV, Waddell N, Kassahn KS, Gingras MC, Muthuswamy LB, Johns AL, et al. Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature. 2012;491(7424):399\u2013405.","journal-title":"Nature"},{"issue":"10","key":"2245_CR12","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1158\/2159-8290.CD-13-0330","volume":"3","author":"SJ Furney","year":"2013","unstructured":"Furney SJ, Pedersen M, Gentien D, Dumont AG, Rapinat A, Desjardins L, et al. SF3B1 mutations are associated with alternative splicing in uveal melanoma. Cancer Discov. 2013;3(10):1122\u20139.","journal-title":"Cancer Discov"},{"issue":"5","key":"2245_CR13","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/s41588-018-0078-z","volume":"50","author":"J Armenia","year":"2018","unstructured":"Armenia J, Wankowicz SAM, Liu D, Gao J, Kundra R, Reznik E, et al. The long tail of oncogenic drivers in prostate cancer. Nat Genet. 2018;50(5):645\u201351.","journal-title":"Nat Genet"},{"issue":"12","key":"2245_CR14","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1182\/blood-2018-04-843771","volume":"132","author":"A Pellagatti","year":"2018","unstructured":"Pellagatti A, Armstrong RN, Steeples V, Sharma E, Repapi E, Singh S, et al. Impact of spliceosome mutations on RNA splicing in myelodysplasia: dysregulated genes\/pathways and clinical associations. Blood. 2018;132(12):1225\u201340.","journal-title":"Blood"},{"issue":"5","key":"2245_CR15","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.celrep.2015.09.053","volume":"13","author":"RB Darman","year":"2015","unstructured":"Darman RB, Seiler M, Agrawal AA, Lim KH, Peng S, Aird D, et al. Cancer-associated SF3B1 hotspot mutations induce cryptic 3\u2032 splice site selection through use of a different branch point. Cell Rep. 2015;13(5):1033\u201345.","journal-title":"Cell Rep"},{"issue":"1","key":"2245_CR16","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1038\/s41467-020-16052-8","volume":"11","author":"C Li","year":"2020","unstructured":"Li C, Xie W, Rosenblum JS, Zhou J, Guo J, Miao Y, et al. Somatic SF3B1 hotspot mutation in prolactinomas. Nat Commun. 2020;11(1):2506.","journal-title":"Nat Commun"},{"issue":"51","key":"2245_CR17","doi-asserted-by":"publisher","first-page":"E5593","DOI":"10.1073\/pnas.1419161111","volume":"111","author":"S Shen","year":"2014","unstructured":"Shen S, Park JW, Lu ZX, Lin L, Henry MD, Wu YN, et al. rMATS: robust and flexible detection of differential alternative splicing from replicate RNA-Seq data. Proc Natl Acad Sci U S A. 2014;111(51):E5593\u2013601.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"14","key":"2245_CR18","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Durbin R. Fast and accurate short read alignment with burrows-wheeler transform. Bioinformatics. 2009;25(14):1754\u201360.","journal-title":"Bioinformatics"},{"issue":"16","key":"2245_CR19","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al. Genome project data processing S: the sequence alignment\/map format and SAMtools. Bioinformatics. 2009;25(16):2078\u20139.","journal-title":"Bioinformatics"},{"issue":"1","key":"2245_CR20","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nbt.1754","volume":"29","author":"JT Robinson","year":"2011","unstructured":"Robinson JT, Thorvaldsdottir H, Winckler W, Guttman M, Lander ES, Getz G, et al. Integrative genomics viewer. Nat Biotechnol. 2011;29(1):24\u20136.","journal-title":"Nat Biotechnol"},{"issue":"12","key":"2245_CR21","doi-asserted-by":"publisher","first-page":"6391","DOI":"10.1210\/jc.2018-02544","volume":"104","author":"C Lei","year":"2019","unstructured":"Lei C, Jing G, Jichao W, Xiaohui L, Fang Q, Hua G, et al. MiR-137\u2019s tumor suppression on Prolactinomas by targeting MITF and modulating Wnt signaling pathway. J Clin Endocrinol Metab. 2019;104(12):6391\u2013402.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2245_CR22","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.ccell.2016.10.005","volume":"30","author":"L Wang","year":"2016","unstructured":"Wang L, Brooks AN, Fan J, Wan Y, Gambe R, Li S, et al. Transcriptomic characterization of SF3B1 mutation reveals its pleiotropic effects in chronic lymphocytic leukemia. Cancer Cell. 2016;30(5):750\u201363.","journal-title":"Cancer Cell"},{"issue":"1","key":"2245_CR23","doi-asserted-by":"publisher","first-page":"3649","DOI":"10.1038\/s41467-018-06063-x","volume":"9","author":"Y Shiozawa","year":"2018","unstructured":"Shiozawa Y, Malcovati L, Galli A, Sato-Otsubo A, Kataoka K, Sato Y, et al. Aberrant splicing and defective mRNA production induced by somatic spliceosome mutations in myelodysplasia. Nat Commun. 2018;9(1):3649.","journal-title":"Nat Commun"},{"issue":"2","key":"2245_CR24","doi-asserted-by":"publisher","first-page":"e615","DOI":"10.1210\/clinem\/dgaa744","volume":"106","author":"K Kim","year":"2021","unstructured":"Kim K, Park YW, Kim D, Ahn SS, Moon JH, Kim EH, et al. Biochemical remission after Cabergoline withdrawal in hyperprolactinemic patients with visible remnant pituitary adenoma. J Clin Endocrinol Metab. 2021;106(2):e615\u201324.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1\u20132","key":"2245_CR25","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s10555-008-9169-0","volume":"28","author":"M Yilmaz","year":"2009","unstructured":"Yilmaz M, Christofori G. EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev. 2009;28(1\u20132):15\u201333.","journal-title":"Cancer Metastasis Rev"},{"issue":"6","key":"2245_CR26","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.devcel.2018.05.027","volume":"45","author":"NM Aiello","year":"2018","unstructured":"Aiello NM, Maddipati R, Norgard RJ, Balli D, Li J, Yuan S, et al. EMT subtype influences epithelial plasticity and mode of cell migration. Dev Cell. 2018;45(6):681\u2013695 e684.","journal-title":"Dev Cell"},{"key":"2245_CR27","doi-asserted-by":"publisher","first-page":"e116","DOI":"10.1038\/cddis.2010.92","volume":"2","author":"S Ivanova","year":"2011","unstructured":"Ivanova S, Gregorc U, Vidergar N, Javier R, Bredt DS, Vandenabeele P, et al. MAGUKs, scaffolding proteins at cell junctions, are substrates of different proteases during apoptosis. Cell Death Dis. 2011;2:e116.","journal-title":"Cell Death Dis"},{"issue":"19","key":"2245_CR28","doi-asserted-by":"publisher","first-page":"3538","DOI":"10.1111\/j.1742-4658.2012.08699.x","volume":"279","author":"F Facciuto","year":"2012","unstructured":"Facciuto F, Cavatorta AL, Valdano MB, Marziali F, Gardiol D. Differential expression of PDZ domain-containing proteins in human diseases - challenging topics and novel issues. FEBS J. 2012;279(19):3538\u201348.","journal-title":"FEBS J"},{"issue":"9","key":"2245_CR29","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1038\/bjc.2016.24","volume":"114","author":"T Sugihara","year":"2016","unstructured":"Sugihara T, Nakagawa S, Sasajima Y, Ichinose T, Hiraike H, Kondo F, et al. Loss of the cell polarity determinant human discs-large is a novel molecular marker of nodal involvement and poor prognosis in endometrial cancer. Br J Cancer. 2016;114(9):1012\u20138.","journal-title":"Br J Cancer"},{"key":"2245_CR30","doi-asserted-by":"publisher","first-page":"10615","DOI":"10.1038\/ncomms10615","volume":"7","author":"S Alsafadi","year":"2016","unstructured":"Alsafadi S, Houy A, Battistella A, Popova T, Wassef M, Henry E, et al. Cancer-associated SF3B1 mutations affect alternative splicing by promoting alternative branchpoint usage. Nat Commun. 2016;7:10615.","journal-title":"Nat Commun"},{"issue":"6","key":"2245_CR31","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1158\/2159-8290.CD-19-1330","volume":"10","author":"Z Liu","year":"2020","unstructured":"Liu Z, Yoshimi A, Wang J, Cho H, Chun-Wei Lee S, Ki M, et al. Mutations in the RNA splicing factor SF3B1 promote tumorigenesis through MYC stabilization. Cancer Discov. 2020;10(6):806\u201321.","journal-title":"Cancer Discov"},{"key":"2245_CR32","doi-asserted-by":"crossref","unstructured":"Liu B, Liu Z, Chen S, Ki M, Erickson C, Reis-Filho JS, et al. Mutant SF3B1 promotes AKT- and NF-kappaBdriven mammary tumorigenesis. J Clin Invest. 2021;131(1):e138315.","DOI":"10.1172\/JCI138315"},{"issue":"3","key":"2245_CR33","doi-asserted-by":"publisher","first-page":"e1004105","DOI":"10.1371\/journal.pcbi.1004105","volume":"11","author":"C DeBoever","year":"2015","unstructured":"DeBoever C, Ghia EM, Shepard PJ, Rassenti L, Barrett CL, Jepsen K, et al. Transcriptome sequencing reveals potential mechanism of cryptic 3\u2032 splice site selection in SF3B1-mutated cancers. PLoS Comput Biol. 2015;11(3):e1004105.","journal-title":"PLoS Comput Biol"},{"issue":"11","key":"2245_CR34","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/nrm3454","volume":"13","author":"S Kervestin","year":"2012","unstructured":"Kervestin S, Jacobson A. NMD: a multifaceted response to premature translational termination. Nat Rev Mol Cell Biol. 2012;13(11):700\u201312.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2245_CR35","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.trsl.2019.07.001","volume":"212","author":"JM Jimenez-Vacas","year":"2019","unstructured":"Jimenez-Vacas JM, Herrero-Aguayo V, Gomez-Gomez E, Leon-Gonzalez AJ, Saez-Martinez P, Alors-Perez E, et al. Spliceosome component SF3B1 as novel prognostic biomarker and therapeutic target for prostate cancer. Transl Res. 2019;212:89\u2013103.","journal-title":"Transl Res"},{"key":"2245_CR36","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.canlet.2020.10.010","volume":"496","author":"JL Lopez-Canovas","year":"2021","unstructured":"Lopez-Canovas JL, Del Rio-Moreno M, Garcia-Fernandez H, Jimenez-Vacas JM, Moreno-Montilla MT, Sanchez-Frias ME, et al. Splicing factor SF3B1 is overexpressed and implicated in the aggressiveness and survival of hepatocellular carcinoma. Cancer Lett. 2021;496:72\u201383.","journal-title":"Cancer Lett"},{"key":"2245_CR37","doi-asserted-by":"crossref","unstructured":"Vazquez-Borrego MC, Fuentes-Fayos AC, Venegas-Moreno E, Rivero-Cortes E, Dios E, Moreno-Moreno P, et al. Splicing machinery is dysregulated in pituitary neuroendocrine tumors and is associated with aggressiveness features. Cancers (Basel). 2019;11(10):1439.","DOI":"10.3390\/cancers11101439"},{"issue":"55","key":"2245_CR38","doi-asserted-by":"publisher","first-page":"6888","DOI":"10.1038\/onc.2008.341","volume":"27","author":"PO Humbert","year":"2008","unstructured":"Humbert PO, Grzeschik NA, Brumby AM, Galea R, Elsum I, Richardson HE. Control of tumourigenesis by the scribble\/Dlg\/Lgl polarity module. Oncogene. 2008;27(55):6888\u2013907.","journal-title":"Oncogene"},{"issue":"6812","key":"2245_CR39","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/35046094","volume":"408","author":"CY Peng","year":"2000","unstructured":"Peng CY, Manning L, Albertson R, Doe CQ. The tumour-suppressor genes lgl and dlg regulate basal protein targeting in Drosophila neuroblasts. Nature. 2000;408(6812):596\u2013600.","journal-title":"Nature"},{"issue":"1","key":"2245_CR40","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/ncb897","volume":"5","author":"D Bilder","year":"2003","unstructured":"Bilder D, Schober M, Perrimon N. Integrated activity of PDZ protein complexes regulates epithelial polarity. Nat Cell Biol. 2003;5(1):53\u20138.","journal-title":"Nat Cell Biol"},{"issue":"55","key":"2245_CR41","doi-asserted-by":"publisher","first-page":"7003","DOI":"10.1038\/onc.2008.350","volume":"27","author":"ED Hawkins","year":"2008","unstructured":"Hawkins ED, Russell SM. Upsides and downsides to polarity and asymmetric cell division in leukemia. Oncogene. 2008;27(55):7003\u201317.","journal-title":"Oncogene"},{"issue":"3","key":"2245_CR42","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/nrm3758","volume":"15","author":"S Lamouille","year":"2014","unstructured":"Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 2014;15(3):178\u201396.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"2245_CR43","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/s41419-018-0262-1","volume":"9","author":"Y Lan","year":"2018","unstructured":"Lan Y, Han J, Wang Y, Wang J, Yang G, Li K, et al. STK17B promotes carcinogenesis and metastasis via AKT\/GSK-3beta\/snail signaling in hepatocellular carcinoma. Cell Death Dis. 2018;9(2):236.","journal-title":"Cell Death Dis"},{"issue":"10","key":"2245_CR44","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/j.ctrv.2014.09.005","volume":"40","author":"H Stegeman","year":"2014","unstructured":"Stegeman H, Span PN, Kaanders JH, Bussink J. Improving chemoradiation efficacy by PI3-K\/AKT inhibition. Cancer Treat Rev. 2014;40(10):1182\u201391.","journal-title":"Cancer Treat Rev"},{"issue":"10","key":"2245_CR45","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/ncb1173","volume":"6","author":"BP Zhou","year":"2004","unstructured":"Zhou BP, Deng J, Xia W, Xu J, Li YM, Gunduz M, et al. Dual regulation of snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat Cell Biol. 2004;6(10):931\u201340.","journal-title":"Nat Cell Biol"},{"issue":"5","key":"2245_CR46","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1073\/pnas.1110120109","volume":"109","author":"A Zanin-Zhorov","year":"2012","unstructured":"Zanin-Zhorov A, Lin J, Scher J, Kumari S, Blair D, Hippen KL, et al. Scaffold protein disc large homolog 1 is required for T-cell receptor-induced activation of regulatory T-cell function. Proc Natl Acad Sci U S A. 2012;109(5):1625\u201330.","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-022-02245-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-022-02245-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-022-02245-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T22:07:08Z","timestamp":1666649228000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-022-02245-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,17]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2245"],"URL":"https:\/\/doi.org\/10.1186\/s13046-022-02245-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-934219\/v1","asserted-by":"object"}]},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,17]]},"assertion":[{"value":"23 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by The Ethics Committees of Beijing Tiantan Hospital. All subjects provided written informed consent. The animal experiments were approved by the Animal Use and Care Committee of Beijing Tiantan Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26"}}